Consistent with these results, analysis of cancer database48 revealed that cancer patients with a lower level of DNAJA2 (DNAJA2-low) displayed a better surviving rate than those with a higher level of DNAJA2 (DNAJA2-high) in several types of cancers analyzed, including lung and breast cancers (Fig. 7g), as well as colorectal cancers, neuroblastoma and myeloma (Supplementary Fig. 7b). This evidence concerns the gene DNAJA2 and cancer.